Article
The emerging clinical relevance of genomic profiling in neuroendocrine tumours.
BMC cancer - 6 Mar 2021
Burak Guney Isa, Ozge Sonmezler, Cem Mujde, Gulgun Buyukdereli, Zeynep Dogruca Yapar, Atil Bisgin
Abstract excerpt
BACKGROUND: Neuroendocrine tumours (NETs) arise from hormone-producing or nervous system cells and can develop from anywhere in the body. They have heterogeneous origins from skin to gastrointestinal track and a complicated histology. Thus, there is an inevitable need for genomic profiling to determine the exact genetics of each tumour for prognosis and treatment strategies to overcome the disease's complexity....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
